Gemcitabine, oxaliplatin, 5-FU and folinic acid as an outpatient first-line therapy in patients with inoperable esophageal cancer: A phase I study No significant financial relationships to disclose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results